The BRS 2024 annual meeting will attract around 200 delegates from across the country and beyond. Exhibiting at our meeting will give you access to leading experts in the field of Bone Research. The exhibition will be held in the main Dining Hall on the ground floor of the Edge where posters and catering are integrated allowing for a central area for networking.
You can find more detailed information about the Sponsorship opportunities available HERE.
We wish to thank the following industry partners for their confirmed support to the BRS Annual Meeting 2024.
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Specialty Pharmaceutical Company with a heritage of 70+ years, we apply cutting-edge science including an expertise in antibody research and engineering, to address the needs of patients and society across multiple therapeutic areas including Nephrology, Oncology, Immunology/Allergy and Neurology. Across our four regions – Japan, Asia Pacific, North America and EMEA/International – we focus on our purpose, to make people smile, and are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity.
You can learn more about the business of Kyowa Kirin at: https://international.kyowa-kirin.com/uk/
BlueScientific is a distributor of market-leading scientific instrumentation for research, development and process control in both the academic and industrial markets across the UK, Ireland and Nordic region (Denmark, Sweden, Finland, Iceland and Norway).
We are the official distributor of Bruker's range of X-Ray Microscopes (XRM), also known as Micro-CT. Micro-CT is a non-destructive 3D imaging and analysis technique. It can be used to examine the internal structure of a huge variety of samples. Using the same method as hospital CT scans, but on a smaller scale with dramatically increased resolution. The results represent 3D microscopy, revealing the internal structures of objects at a very fine scale.
For bone research, micro-CT is faster than histology or slicing. Acquire a scan in 10-15 minutes (medium resolution) or a few hours (high resolution) and generate 3D reconstructions in minutes.
In dental applications, microtomography delivers fine, highly detailed images at micrometre scale. It’s non-destructive, so you can take multiple scans, as well as virtual slices and flights through your sample.
Our website address is: https://blue-scientific.com/
CompagOs, a Swiss startup from ETH Zürich, develops diagnostic and research tools utilizing 3D-bioprinted, mineralized, and multicellular in vitro bone models.
Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases driven by pathologic mineralization and intimal proliferation which impact the vasculature, soft tissue and skeleton.
We are initially focused on developing an enzyme therapy to treat ENPP1 and ABCC6 Deficiencies, rare genetic diseases associated with significant morbidity, mortality, and unmet medical need.
Please get in touch if you encounter potential subjects for our clinical trials program.
Please do visit our website for more information - link the webpage is www.scanco.ch.
We are Theramex, a global speciality pharmaceutical company solely committed to supporting the health needs of women through every stage of life. We work on patient-focused, effective solutions that support women of all ages.
We work closely with our partners, healthcare professionals, and patients to provide women with the right solution, at the time they most need it.
We believe in empowering women to make informed decisions about how to manage the natural cycles and stages of their life. To do this, we provide education and support around contraception, fertility and menopause.
Wonderful Scientific is the proud distributor of Neoscan.com benchtop Micro-CT products in the UK and Ireland. The N80 scanner is the best in class scanner and is ideal for high resolution bone analysis and visualisation of osteocyte lacunae. The N80 has a sealed transmission X-ray source with a 2um spot size and movable target repositioning, radiation hardened camera protection, 2: fibre optics, active artefact suppression, new precision stepper motors and all new software. The resulting benefits make it the most robust, long lasting, advanced and highest resolution benchtop Micro-CT on the market today.
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Specialty Pharmaceutical Company with a heritage of 70+ years, we apply cutting-edge science including an expertise in antibody research and engineering, to address the needs of patients and society across multiple therapeutic areas including Nephrology, Oncology, Immunology/Allergy and Neurology. Across our four regions – Japan, Asia Pacific, North America and EMEA/International – we focus on our purpose, to make people smile, and are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity.
You can learn more about the business of Kyowa Kirin at: https://international.kyowa-kirin.com/uk/
Mereo is an agile biotech company, focused on finding, developing and bringing to market therapies that will improve the lives of people living with rare conditions.
We are driven by a true understanding of the critical nature of our mission and we combine three core elements to create new possibilities for patients who need new treatment options: the power of science; our knowledge of the rare diseases we seek to treat; and our daily commitment to develop deep, durable and authentic relationships with all our stakeholders.
Central to every decision and action at Mereo are the communities that we are here to serve. Each member of our team is committed to building personal understanding about what will make a real difference to those communities and to bring this understanding back to our shared work together to deliver new treatments in a timely and sustainable way.
The Bone Cancer Research Trust is the leading charity dedicated to fighting primary bone cancer; we are uniquely placed to make a difference through research, information, awareness, and support.
We aim to be a catalyst for pioneering research that saves lives and improves outcomes for patients with primary bone cancer, supporting much-needed advancements towards kinder, more targeted treatments. We therefore offer a diverse range of research grants for researchers at all stages in their career, with interests directly or indirectly aligned to primary bone cancer. This encompasses a wide variety of disciplines, and we are proud to fund researchers and clinicians with expertise in bone disease and biology, chemistry, biomaterials, medical engineering, pathology, and much more.
Our grant programme ranges from small scale Idea Grants and funding for research meetings, to larger scale Research Projects, Translational Grants, PhD Studentships, Early Career Fellowships and Consortia funding.
This year, we are delighted to offer Skills Development Grants up to £300 for delegates attending the Bone Research Society Annual Meeting 2024. Our Skills Development Grants support UK-based researchers to travel nationally & internationally, attending conferences, courses, and laboratories, providing them with vital skills development and networking opportunities.
For further information, please contact research@bcrt.org.uk.
For further information and queries about sponsorship and exhibiting opportiunities, please contact the BRS Event Team:
